Abbott/Cholestech Cholestech Ldx Analyzer

The Abbott/Cholestech LDX Analyzer is available in several Factory New, CLIA Waived (Rx) configurations, offering flexible purchasing options for professional diagnostic settings.

Configurations fall into two main categories:

1. Core LDX Analyzer Systems (Hardware Focus)

These options provide the diagnostic unit and necessary accessories:

• LDX Analyzer Only: The core diagnostic unit (note: sometimes restricted to Authorized Dealers).
• LDX Analyzer with Printer: Includes the analyzer unit plus a printer.
• LDX System (Complete Bundle): The most comprehensive hardware setup, including the Analyzer, Printer with Cable, Starter Kit, Accessory Tray, Optics Check, power cord, user manuals, and training materials.

2. New Customer Kits (Analyzer + Consumables)

These bundles combine the complete LDX System hardware with essential testing consumables and controls, tailored for specific testing panels:

• New Customer Lipid Kit
• New Customer Lipid/Glucose Kit
• New Customer TC/HDL Kit (Note: Purchase of this variant may require a Meter Placement Agreement (MPA)).
• New Customer TC/HDL Glucose Kit

The Abbott/Cholestech Cholestech Ldx Analyzer is a CLIA Waived device specialized for rapid, in-vitro diagnostic testing, focusing primarily on lipid and glucose analysis at the point of care. The specific tests performed depend on the assay cassette configuration selected.

Capabilities include:

• Lipid Panel Components: Total Cholesterol (TC) and High-Density Lipoprotein (HDL).
• Glucose Measurement (when using Glucose-enabled cassettes).

Various kit configurations are available (such as Lipid, Lipid/Glucose, TC/HDL, or TC/HDL Glucose kits) to suit different clinical screening needs.

Yes, as the Abbott/Cholestech Ldx Analyzer is a professional, CLIA Waived diagnostic device, specific purchasing and usage restrictions apply:

• Regulatory Status: The device is designated as CLIA Waived (Rx), meaning it is intended for professional use in waived testing environments and requires prescription authorization.
• Authorized Dealers: Certain standalone configurations, such as the LDX Analyzer Only, are restricted to purchase by Authorized Dealers Only.
• Specific Kit Requirements: If you are purchasing certain New Customer Kits (like the TC/HDL Kit), you may be required to have a signed Meter Placement Agreement (MPA). The product information advises contacting your local Abbott representative for details on these restrictions.
• Geographic Restrictions: Some configurations are limited to specific regions (e.g., Continental US Only + AK & HI).

Yes, purchasing the Abbott/Cholestech Ldx Analyzer is subject to specific regulatory and contractual requirements, which vary depending on the configuration you select.

Key restrictions and requirements include:

• CLIA Waived (Rx) Status: All configurations are classified as CLIA Waived (Rx), meaning this diagnostic device is intended for Prescription Use Only in waived testing environments.
• Authorized Dealer Restriction: Certain configurations, such as the stand-alone LDX Analyzer Only unit, are restricted for purchase by Authorized Dealers Only.
• Meter Placement Agreement (MPA): Specific bundles, such as the New Customer TC/HDL Kit, may require a Meter Placement Agreement (MPA).
• Geographic Restrictions: Some configurations are restricted to specific geographic areas, such as the Continental US plus Alaska and Hawaii.

The LDX Analyzer is designed for rapid, point-of-care diagnostic testing focused on lipid panels and glucose measurements. The specific tests performed depend on the assay cassette configuration utilized.

The system supports testing for:

• Total Cholesterol (TC)
• HDL Cholesterol
• Glucose

A major benefit is that all supported tests fall under the CLIA Waived (Rx) designation, simplifying regulatory requirements for use in clinical environments. Configurations are available to bundle these tests (e.g., Lipid, Lipid/Glucose, TC/HDL, or TC/HDL Glucose kits).

The Abbott/Cholestech Ldx Analyzer is indeed designated as CLIA Waived (Rx) across all available system and kit configurations. This status is a major advantage for clinical settings as it significantly simplifies regulatory compliance, meeting the requirements of the Clinical Laboratory Improvement Amendments for waived testing.

Note: Because this is an (Rx) device, it is strictly intended for professional use and requires a prescription.

The Abbott/Cholestech LDX Analyzer is designated as CLIA Waived (Rx), certifying it for use in low-complexity diagnostic settings. This makes the system ideal for point-of-care environments where professional users need quick and efficient access to test results for:

• Lipid profiles
• Lipid/Glucose profiles
• TC/HDL profiles

Its design and regulatory status support its role as a key tool for immediate clinical decision-making.

The Abbott/Cholestech Cholestech LDX Analyzer is a factory new product, guaranteeing optimal performance and reliability from the start.

Yes, the Abbott/Cholestech Cholestech Ldx Analyzer is a sophisticated diagnostic instrument designed for rapid, point-of-care testing of both lipids and glucose. A key advantage is that the system is certified for CLIA Waived (Rx) testing, streamlining compliance for certain clinical environments.

Depending on the reagent cassette utilized (available in various kits), the analyzer supports comprehensive analysis of key metrics, including:

• Total Cholesterol (TC)
• HDL (High-Density Lipoprotein)
• Glucose

Specific kit configurations are available to support various combined panels, such as Lipid, Lipid/Glucose, or TC/HDL testing, allowing healthcare providers to quickly assess cardiovascular risk and metabolic status.

The lead time for the Abbott/Cholestech Cholestech Ldx Analyzer is typically 1-2 weeks as it ships directly from the manufacturer. Please note that availability may be limited due to manufacturer backorders.